There are many roads one can travel on within the world of medicine. Some take their training down the pathway of clinical practice and patient care. Other will steer themselves toward the scholarly street of science and studies. A few apply their brains to the boulevard of books and blogs. And some head straight for the Interstate and become internationally recognized innovators.
But a few, very few, actually manage to do all of the above…and more.
It is a great honor to be able to interview one such individual who will, for many readers, need no introduction at all. Dr. David Healy is an internationally respected psychiatrist, psychopharmacologist, scientist, and author. A professor of Psychiatry in Wales and former Secretary of the British Association for Psychopharmacology he has written numerous peer-reviewed papers, articles and is the author of 20 books, including his latest entitled Pharmageddon.
David is also one of the founding leaders associated with the www.RxISK.org website, a “free, independent website where patients, doctors, and pharmacists can research prescription drugs and easily report a drug side effect — identifying problems and possible solutions earlier than is currently happening.“ He is, as we say, a 10 talent man.
It is an extraordinary privilege and honor to have David answer a few questions about his work for us here at The Honest Apothecary. He is an advocate for patients, and is very supportive of the role of pharmacists to educate patients about their medications. I do hope you enjoy listening in.
Read the full interview: The Honest Apothecary: Pharmageddon, RxISK.org, and an interview with Dr. David Healy
I am an UK pharmacist. Can you tell me how UK patients can send in their ADR reports formed on your website to the MHRA in UK please? Obviously I cannot see this as I haven’t got a report to send it at present, but I am interested to see how it links in.
At the end of the report, there is an option send to the MHRA. The option is send to the regulator in whichever country you are reporting from. What happens then is that we autopopulate the MHRAs yellow card form and let you print if off. Until MHRA provide us with the kind of electronic portal they give to drug companies, it would be a breach of privacy regulations for us to submit without your approval and if we were to submit all those approved it would cost too much for us to submit them all. So what we offer is an autopopulated form that you can print off and submit. We encourage submission.